Evan Seigerman, BMO Capital Markets biotech analyst, joins 'Power Lunch' to discuss his takeaways from Eli Lilly earnings..
Back to Health PageEvan Seigerman, BMO Capital Markets biotech analyst, joins 'Power Lunch' to discuss his takeaways from Eli Lilly earnings.
Evan Seigerman, BMO Capital Markets biotech analyst, joins 'Power Lunch' to discuss his takeaways from Eli Lilly earnings..
Back to Health Page